Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersDouglas B. Johnson, Joseph I. Clark, Donald P. Lawrence et al.|JAMA Oncology|2015Cited by 656
A phase II, randomized study of nivolumab (NIVO) and Ipilimumab (IPI) versus NIVO, IPI and stereotactic body radiation therapy (SBRT) for metastatic Merkel cell carcinoma (MCC, NCT03071406): A preliminary reportS. Kim, Andrew S. Brohl, Nikhil I. Khushalani et al.|Annals of Oncology|2019Cited by 5
Extracranial Melanoma Metastases Treated with Stereotactic Body Radiation Therapy and Immune Checkpoint InhibitorsKamran A. Ahmed, J.J. Caudell, Andrew Keller et al.|International Journal of Radiation Oncology*Biology*Physics|2017Cited by 0
LBA42 Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinomaS. Kim, Andrew S. Brohl, Evan Wuthrick et al.|Annals of Oncology|2022Cited by 0